Form 8-K - Current report:
SEC Accession No. 0001104659-22-079571
Filing Date
2022-07-13
Accepted
2022-07-13 16:55:10
Documents
27
Period of Report
2022-07-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2220905d2_8k.htm   iXBRL 8-K 32935
2 EXHIBIT 99.1 tm2220905d2_ex99-1.htm EX-99.1 25881
3 EXHIBIT 99.2 tm2220905d2_ex99-2.htm EX-99.2 22245
7 GRAPHIC tm2220905d2_ex99-2img001.jpg GRAPHIC 165279
8 GRAPHIC tm2220905d2_ex99-2img002.jpg GRAPHIC 440338
9 GRAPHIC tm2220905d2_ex99-2img003.jpg GRAPHIC 329737
10 GRAPHIC tm2220905d2_ex99-2img004.jpg GRAPHIC 252867
11 GRAPHIC tm2220905d2_ex99-2img005.jpg GRAPHIC 447322
12 GRAPHIC tm2220905d2_ex99-2img006.jpg GRAPHIC 176432
13 GRAPHIC tm2220905d2_ex99-2img007.jpg GRAPHIC 199073
14 GRAPHIC tm2220905d2_ex99-2img008.jpg GRAPHIC 121363
15 GRAPHIC tm2220905d2_ex99-2img009.jpg GRAPHIC 275485
16 GRAPHIC tm2220905d2_ex99-2img010.jpg GRAPHIC 128661
17 GRAPHIC tm2220905d2_ex99-2img011.jpg GRAPHIC 78396
18 GRAPHIC tm2220905d2_ex99-2img012.jpg GRAPHIC 189590
19 GRAPHIC tm2220905d2_ex99-2img013.jpg GRAPHIC 100252
  Complete submission text file 0001104659-22-079571.txt   4278010

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tbph-20220713.xsd EX-101.SCH 3039
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbph-20220713_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbph-20220713_pre.xml EX-101.PRE 22599
21 EXTRACTED XBRL INSTANCE DOCUMENT tm2220905d2_8k_htm.xml XML 3620
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 221081488
SIC: 2834 Pharmaceutical Preparations